News & Insights
Funding will fuel company's continued growth and expansion, including development of an international sales team, expansion of its software engineering team and marketing dollars to support Avec®.
As we continue to expand our national sales team, we'd like to welcome Mario Bienvenue to Signet Accel. With more than 30 years' experience in technology, Mario has spent the last 12 years of his career focused on HIT--most recently as a senior sales consultant at Core Solutions, Inc.
For more than a decade, healthcare interoperability has been top of mind for IT leaders, practitioners, investigators and administrators. Tens of billions of dollars have been spent enabling the capture and storage of data, with the end goal of utilizing it to the benefit of patients. And still, we wait.
In June 2016, Signet Accel had the honor of attending the National Cancer Moonshot Summit at Howard University, an initiative created under President Obama. One year later, the administration has changed and our healthcare system may as well—but former Vice President Joe Biden’s commitment to bring more data to the fight against cancer remains.
We asked healthcare IT and informaticists three simple questions. Here’s what we learned.
Seasoned executive Brenda Berry joins fast-growing healthcare software and services company; charged with leading and expanding national sales team in continued growth trajectory.
Value-based care is a critical goal, but one that can be complex to operationalize. And yet, it is well worth striving to achieve. Getting there requires a connected healthcare system that does not yet fully exist. I recently collaborated with colleagues and the American Medical Informatics Association to co-author a paper detailing this gap—the chasm between our current health IT ecosystem and the ecosystem that we need to solidify—a crack that must be closed if true value-based care and a learning health system are to be realized.
The fields of healthcare and life science are experiencing massive change, due to economic, policy and technological factors. At their core, the shifts center around the pursuits of precision medicine and value-based care.